Skip to main content
. 2020 Nov 6;12(11):1267. doi: 10.3390/v12111267

Figure 2.

Figure 2

The efficiencies of bioactive peptide inhibitors on dengue virus (DENV) infection. The efficiencies of peptide inhibitors to inhibit DENV2 infection in Vero cells was determined. DENV2 was treated with various concentrations of the peptide inhibitors Pep-RTYM, Pep-WAYF, or Pep-CORE prior to virus infection. Reduction of focus forming units was determined, and the IC50 value for Pep-RTYM (A), Pep-WAYF (B), and Pep-CORE (C) was determined by non-linear regression analysis.